1.
Dolatkhah R, Jam EI, Nikanfar A, Esfahani A, Chavooshi SH, Nejati B, Sanaat Z. Outcome analysis of acute myeloid leukemia patients treated with high dose daunorubicin. BMRAT [Internet]. 10Sep.2019 [cited 20May2024];6(9):3347-51. Available from: http://home.biomedpress.org/index.php/BMRAT/article/view/562